Inovio Faces Securities Class Action Over Undisclosed Manufacturing Delays, FDA Review Setbacks
Law firm Levi & Korsinsky seeks investors in Inovio Pharmaceuticals securities class action alleging failure to disclose manufacturing delays and FDA's standard review decision.
INOsecurities class actionFDA approval